The membership of PPTA includes the collectors of source plasma and manufacturers of plasma-derived and recombinant analog therapies. Member companies are represented on the global and regional Board of Directors, the Global Management Committee and steering committees and taskforces.
Working cooperatively with consumer groups, policy makers and other key stakeholders, PPTA addresses critical issues that affect the industry and patients who rely on plasma protein therapies.
The Plasma Protein Therapeutics Association (PPTA) is an essential part of the plasma protein therapeutics industry, representing a broad spectrum of firms, large, multi-national companies and small businesses.
For information on how to become a member of PPTA, contact the Membership Services office of PPTA, by calling 202.789.3100 or by emailing firstname.lastname@example.org.
The Hilfenhaus Award conferred to Prof. Farkas at the IPPC 2017 +
The 2017 Hilfenhaus Award was bestowed to Professor Henriette Farkas, MD, Ph.D., DSc, during IPPC 2017 for her work related to treating those suffering from Hereditary Angioedema (HAE) and working to improve treatments and patients’ quality of life. She is professor of allergology and clinical immunology at the Hungarian Angioedema Center at Semmelweis University in Budapest, Hungary.Read More
Highlights from IPPC 2017 +
Mr. Bruno Santoni, Executive Director, PPTA Europe, opened the well-attended IPPC 2017 welcoming the more than 300 attendees to Prague. PPTA thanks its sponsors who help make the IPPC possible. Download the IPPC app for a complete list of sessions and many of the presentations.Read More
PPTA Remembers John W. Walsh +